Diagnostic Value of Anti-HTLV-1-Antibody Quantification in Cerebrospinal Fluid for HTLV-1-Associated Myelopathy
Viruses · 2024
DOI: 10.3390/v16101581 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Tomoo Sato und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki 216-8512, Japan. Hauptthemen laut MEDLINE: Paraparesis, Tropical Spastic, Human T-lymphotropic virus 1, Sensitivity and Specificity. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Labour Sciences Research Grant on Rare and Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan, Practical Research Project for Rare/Intractable Diseases of the Japan Agency for Medical Research and Development, Ministry of Health, Labour, and Welfare of Japan.
Abstract (Originalsprache)
The diagnostic accuracy of cerebrospinal fluid (CSF) anti-human T-cell leukemia virus type I (HTLV-1) antibody testing for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM) remains unclear. Therefore, we measured the anti-HTLV-1 antibody levels in CSF using various test kits, evaluated the stability of CSF antibodies, and performed a correlation analysis using the particle agglutination (PA) method, as well as a receiver operating characteristic (ROC) analysis between patients with HAM and carriers. The CSF anti-HTLV-1 antibody levels were influenced by freeze–thaw cycles but remained stable when the CSF was refrigerated at 4 °C for up to 48 h. Measurements from 92 patients (69 patients with HAM and 23 carriers) demonstrated a strong correlation (r > 0.9) with the PA method across all six quantifiable test kits. All six test kits, along with CSF neopterin and CXCL10, exhibited areas under the ROC curve greater than 0.9, indicating a high diagnostic performance for HAM. Among these, five test kits, Lumipulse and Lumipulse Presto HTLV-I/II, HISCL-UD (a kit under development), HTLV-Abbott, and Elecsys HTLV-I/II, established a cutoff with 100% sensitivity and maximum specificity, achieving a sensitivity of 100% and a specificity ranging from 43.5% to 56.5%. This cutoff value, in combination with clinical findings, will aid in the accurate diagnosis of HAM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki 216-8512, Japan.
- Department of Neurology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
- Institute of Radioisotope Research, St. Marianna University Graduate School of Medicine, Kawasaki 216-8512, Japan.
- Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.
- Department of Clinical Laboratory, Subaru Health Insurance Society Ota Memorial Hospital, Ota 373-8585, Japan.
Förderung
- Health and Labour Sciences Research Grant on Rare and Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan
- Practical Research Project for Rare/Intractable Diseases of the Japan Agency for Medical Research and Development
- Ministry of Health, Labour, and Welfare of Japan
Zitieren
APA
Sato, T., Yagishita, N., Araya, N., Nakashima, M., Horibe, E., Takahashi, K., Kunitomo, Y., Nawa, Y., Hamaguchi, I., & Yamano, Y. (2024). Diagnostic Value of Anti-HTLV-1-Antibody Quantification in Cerebrospinal Fluid for HTLV-1-Associated Myelopathy. Viruses. https://doi.org/10.3390/v16101581
Vancouver
Sato T, Yagishita N, Araya N, Nakashima M, Horibe E, Takahashi K, et al. Diagnostic Value of Anti-HTLV-1-Antibody Quantification in Cerebrospinal Fluid for HTLV-1-Associated Myelopathy. Viruses. 2024. doi:10.3390/v16101581
BibTeX
@article{Sato2024,
author = {Sato, Tomoo and Yagishita, Naoko and Araya, Natsumi and Nakashima, Makoto and Horibe, Erika and Takahashi, Katsunori and Kunitomo, Yasuo and Nawa, Yukino and Hamaguchi, Isao and Yamano, Yoshihisa},
title = {Diagnostic Value of Anti-HTLV-1-Antibody Quantification in Cerebrospinal Fluid for HTLV-1-Associated Myelopathy},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16101581}
}
EUVIMED